The pharmacy chain since August 2012 filled prescriptions that lacked a legitimate medical purpose, were invalid or weren’t issued in professional practice, the Justice Department said.

The pharmacy “allowed millions of opioid pills and other controlled substances to flow illegally out of Walgreens stores,” the Justice Department said.

Shares of Walgreens Boots Alliance fell after the Justice Department sued the company for allegedly helping to fuel the opioid crisis. The company's stock fell 9% to $11.39 after the market closed ...

Friday closed up +1.00%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.78%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +1.66%. March E-mini S&P futures (ESH25) are up +0.91%, and ...

The U.S. DOJ files lawsuit against Walgreens for dispensing millions of illegal prescriptions, driving shares down 11% in ...

Over the years the pharmacy chain used strategy to combat shoplifting. Walgreens CEO Tim Wentworth said the company’s ...

Walgreens Boots Alliance (WBA) stands at a pivotal moment as 2025 begins. It is drawing intense investor scrutiny after ...

Walgreens Boots Alliance reported a $245 million operating loss in 2025's first fiscal quarters, the three months ending Nov. 30. Here are 10 things for ASCs to know: 1. The $245 million operating ...

Walgreens' worst day of the year came on June 27, when the stock fell 22% on another disappointing earnings report. This time ...

These four dividend payers are poised to post solid fourth-quarter results and continue to provide way above-average passive ...

A hot December jobs report rattled markets, spurring concern that the Federal Reserve will keep rates higher for longer.

According to CEO Tim Wentworth, the company has been modifying contracts with insurers who pay for prescriptions and adjusting for high-cost drugs. Meanwhile, the VillageMD sale is moving along.